Detection of fluoroquinolone resistance level in clinical canine and feline Escherichia coli pathogens using rapid real-time PCR assay

Veterinary Microbiology

Volumn 139, Issue 3-4, 2009, Pages 379-385

  Shaheen, Bashar W ^a   Wang, Chengming ^a   Johnson, Calvin M ^a   Kaltenboeck, Bernhard ^a   Boothe, Dawn M ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Detection; DNA gyrase; Escherichia coli; FRET

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL MUTATION; CAT; CONTROLLED STUDY; DOG; ESCHERICHIA COLI; FLUORESCENCE RESONANCE ENERGY TRANSFER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; URINALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CAT DISEASES; CATS; DNA GYRASE; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; URINE;

ESCHERICHIA COLI; FELIDAE; NEGIBACTERIA;

EID: 70349895029     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.05.016     Document Type: Article

References (29)

1. Boothe D.M. Principles of antimicrobial therapy. Vet. Clin. North Am. Small Anim. Pract. 36 (2006) 1003-1047
2. Boothe D.M., Boeckh A., Simpson R.B., and Dubose K. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats. J. Vet. Intern. Med. 20 (2006) 1297-1306
3. Bubenik L.J., Hosgood G.L., Waldron D.R., and Snow L.A. Frequency of urinary tract infection in catheterized dogs and comparison of bacterial culture and susceptibility testing results for catheterized and noncatheterized dogs with urinary tract infections. J. Am. Vet. Med. Assoc. 231 (2007) 893-902
4. Chen Y.M., Wright P.J., Lee C.S., and Browning G.F. Uropathogenic virulence factors in isolates of Escherichia coli from clinical cases of canine pyometra and feces of healthy bitches. Vet. Microbiol. 94 (2003) 57-69
5. Clinical and Laboratory Standards Institute, 2008. Performance standards for antimicrobial susceptibility testing, 18th informational supplement. CLSI document M100-S18 Wayne, PA.
6. Cohn L.A., Gary A.T., Fales W.H., and Madsen R.W. Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. J. Vet. Diagn. Invest. 15 (2003) 338-343
7. Cooke C.L., Singer R.S., Jang S.S., and Hirsh D.C. Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J. Am. Vet. Med. Assoc. 15 (2002) 190-192
8. Everett M.J., Jin Y.-F., Ricci V., and Piddock L.J.V. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli isolates from humans and animals. Antimicrob. Agents Chemother. 40 (1996) 2380-2386
9. Giraud E., Leroy-Sétrin S., Flaujac G., Cloeckaert A., Dho-Moulin M., and Chaslus-Dancla E. Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys. J. Antimicrob. Chemother. 47 (2001) 341-343
10. Hagman R., and Kühn I. Escherichia coli strains isolated from the uterus and urinary bladder of bitches suffering from pyometra: comparison by restriction enzyme digestion and pulsed-field gel electrophoresis. Vet. Microbiol. 84 (2002) 143-153
11. Heisig P., Schedletzky H., and Falkenstein-Paul H. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37 (1993) 696-701
12. Hirsh D.C. Multiple antimicrobial resistance in Escherichia coli isolated from the urine of dogs and cats with cystitis. J. Am. Vet. Med. Assoc. 162 (1973) 885-887
13. Hooper D.C. Mechanisms of fluoroquinolone resistance. Drug Resist. Updat. 2 (1999) 38-55
14. Kaltenboeck B., and Wang C. Advances in real-time PCR: application to clinical laboratory diagnostics. Adv. Clin. Chem. 40 (2005) 219-259
15. Ko S., and Grant S.A. A novel FRET-based optical fiber biosensor for rapid detection of Salmonella typhimurium. Biosens. Bioelectron. 21 (2006) 1283-1290
16. Mazzariol A., Tokue Y., Kanegawa T.M., Cornaglia G., and Nikaido H. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother. 44 (2000) 3441-3443
17. Oram M., and Fisher L.M. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35 (1991) 387-389
18. Oethinger M., Kern W.V., Jellen-Ritter A.S., McMurry L.M., and Levy S.B. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44 (2000) 10-13
19. Piddock L.J.V. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58 (1999) 11-18
20. Qiang Y.Z., Qin T., Fu W., Cheng W.P., Li Y.S., and Yi G. Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 49 (2002) 549-552
21. Sáenz Y., Zarazaga M., Briñas L., Ruiz-Larrea F., and Torres C. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals. J. Antimicrob. Chemother. 51 (2003) 1001-1005
22. Shaheen B.W., Boothe D.M., Oyarzabal O.A., and Smaha T. Characterization of clinical Escherichia coli isolates expressing multidrug resistance recovered from canine and feline with spontaneous disease. Congress Proceedings of the ACVIM Forum. San Antonio, TX, June 4-7 (2008) 786
23. Siedner M.J., Pandori M., Castro L., Barry P., Whittington W.L., Liska S., and Klausner J.D. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. J. Clin. Microbiol. 45 (2007) 1250-1254
24. Swanberg S.L., and Wang J.C. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase. J. Mol. Biol. 197 (1987) 729-736
25. Vila J., Ruiz J., Goñi P., and Jiménez de Anta T. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40 (1996) 491-493
26. Wang C., Gao D., Vaglenov A., and Kaltenboeck B. One-step real-time duplex reverse transcription PCRs simultaneously quantify analyte and housekeeping gene mRNAs. Biotechniques 36 (2004) 508-519
27. Weigel L.M., Steward C.D., and Tenover F.C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42 (1998) 2661-2667
28. Willmott C.J.R., and Maxwell A. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother. 37 (1993) 126-127
29. Yoshida H., Bogaki M., Nakamura M., and Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34 (1990) 1271-1272